RichardDHammerMD

Hematopathology, Anatomic Pathology, Clinical Pathology, Surgical Pathology

Professor of Clinical and Anatomic Pathology Director Hematopathology and Coagulation, Core Faculty MU Institute of Data Science and Informatics

Dr. Hammer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Richard Hammer is a pathologist based in Columbia, MO, with subspecialties in hematopathology, anatomic pathology, clinical pathology, and surgical pathology. He graduated from the Medical University of South Carolina in 1988 and completed his residency in pathology, both anatomic and clinical, and a fellowship in hematopathology at Vanderbilt University Medical Center. His areas of experience include clinical decision support and digital pathology. Dr. Hammer has authored several publications, including articles on AML treatment, gene relationship mining, plasma cell analysis, and the application of artificial intelligence in biomedical literature.

Vanderbilt University Medical CenterFellowship, Hematopathology, 1988 - 1996
Vanderbilt University Medical CenterResidency, Pathology-Anatomic and Clinical, 1988 - 1995
Medical University of South CarolinaClass of 1988

PubMed

Inhibiting AGTR1 reduces AML burden and protects the heart from cardiotoxicity in mouse models.
Yi Pan, Chen Wang, WenXuan Zhou, Yao Shi, XiaDuo Meng
Science Translational Medicine. 2024-06-19
1 citations
An alternative processing approach to increase CD138 intensity in flow cytometric analysis of plasma cells.
Deepak Kumar, F N U Kiran, Amanda Wheeler, Rory Dellamano, Richard D Hammer
Cytometry. Part B, Clinical Cytometry. 2024-03-01
2 citations
Iterative Prompt Refinement for Mining Gene Relationships from ChatGPT.
Yibo Chen, Jeffrey Gao, Marius Petruc, Richard D Hammer, Mihail Popescu
Biorxiv. 2023-12-23

Abstracts/Posters

A New Mechanism for T-ALL Leukemogenesis: Early Expression of Alpha-Beta TCR Occurs in a Natural Subset of CD4-CD8- Double Negative (DN) Thymocytes Where MHC Engagemen...
Richard Hammer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Heart Drug Affects Leukemia Responsiveness to ChemotherapyJune 27th, 2024
Study Discovers High Prevalence of COVID & Flu Co-InfectionsNovember 7th, 2022
Study Finds High Prevalence of COVID-19 and Flu Co-Infections During 2021-2022 Flu SeasonNovember 2nd, 2022
Join now to see all